Ophthalmological findings in facioscapulohumeral dystrophy
- PMID: 32954265
- PMCID: PMC7425335
- DOI: 10.1093/braincomms/fcz023
Ophthalmological findings in facioscapulohumeral dystrophy
Abstract
Ophthalmological abnormalities in facioscapulohumeral dystrophy may lead to treatable vision loss, facilitate diagnostics, could help unravelling the pathophysiology and serve as biomarkers. In this study, we provide a detailed description of the ophthalmological findings in a well-defined cohort of patients with facioscapulohumeral dystrophy using state of the art retina imaging techniques. Thirty-three genetically confirmed patients (aged 7-80 years) and 24 unrelated healthy controls (aged 6-68 years) underwent clinical ophthalmological examination, fundus photography, optical coherence tomography/angiography, genotyping and neurological examination. All patients had normal corrected visual acuity and normal intraocular pressure. In 27 of the 33 patients, weakness of the orbicularis oculi was observed. Central retinal pathology, only seen in patients and not in healthy controls, included twisting (tortuosity) of the retinal arteries in 25 of the 33 patients and retinal pigment epithelium defects in 4 of the 33 patients. Asymmetrical foveal hypoplasia was present in three patients, and exudative abnormalities were observed in one patient. There was a correlation between the severity of retinal tortuosity and the D4Z4 repeat array size (R 2 = 0.44, P < 0.005). Follow-up examination in a subgroup of six patients did not show any changes after 2 years. To conclude, retinal abnormalities were frequent but almost always subclinical in patients with facioscapulohumeral dystrophy and consisted primarily of arterial tortuosity and foveal abnormalities. Retinal tortuosity was seen in the retinal arterioles and correlated with the D4Z4 repeat array size, thereby providing clinical evidence for an underlying genetic linkage between the retina and facioscapulohumeral dystrophy.
Keywords: facioscapulohumeral; muscular dystrophy; neuromuscular diseases; retinal telangiectasis.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.
Figures








Similar articles
-
Retinal arterial but not venous tortuosity correlates with facioscapulohumeral muscular dystrophy severity.J AAPOS. 2010 Jun;14(3):240-3. doi: 10.1016/j.jaapos.2010.03.006. J AAPOS. 2010. PMID: 20603058
-
Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.Ophthalmic Genet. 2017 Sep-Oct;38(5):490-493. doi: 10.1080/13816810.2017.1279183. Epub 2017 Jan 25. Ophthalmic Genet. 2017. PMID: 28121209
-
Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications.Brain. 1987 Jun;110 ( Pt 3):631-48. doi: 10.1093/brain/110.3.631. Brain. 1987. PMID: 3580827
-
Facioscapulohumeral muscular dystrophy.Curr Opin Neurol. 1999 Oct;12(5):501-11. doi: 10.1097/00019052-199910000-00003. Curr Opin Neurol. 1999. PMID: 10590886 Review.
-
Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases.Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):1977-1992. doi: 10.1007/s00417-023-06303-x. Epub 2023 Nov 20. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37982887 Review.
Cited by
-
Management of Coats-Like Disease in a Forty-Four-Year-Old Patient with FSHD Type I.Case Rep Ophthalmol. 2023 Jun 16;14(1):250-256. doi: 10.1159/000531007. eCollection 2023 Jan-Dec. Case Rep Ophthalmol. 2023. PMID: 37383166 Free PMC article.
-
Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy.J Clin Invest. 2025 Jul 1;135(17):e181881. doi: 10.1172/JCI181881. eCollection 2025 Sep 2. J Clin Invest. 2025. PMID: 40591405 Free PMC article.
-
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update.Orphanet J Rare Dis. 2021 Mar 12;16(1):129. doi: 10.1186/s13023-021-01760-1. Orphanet J Rare Dis. 2021. PMID: 33712050 Free PMC article. Review.
-
Multimodal Imaging Findings in Retinopathy Associated with Facioscapulohumeral Muscular Dystrophy before and after Treatment with Intravitreal Aflibercept and Laser Photocoagulation.Case Rep Ophthalmol. 2022 Jul 14;13(2):556-561. doi: 10.1159/000525797. eCollection 2022 May-Aug. Case Rep Ophthalmol. 2022. PMID: 36160481 Free PMC article.
-
Morpho-Functional Macular Assessment in a Case of Facioscapulohumeral Muscular Dystrophy: Photoreceptor Degeneration as Possible Cause for Reduced Visual Acuity over Three Years of Follow-Up.Diagnostics (Basel). 2022 Nov 28;12(12):2977. doi: 10.3390/diagnostics12122977. Diagnostics (Basel). 2022. PMID: 36552982 Free PMC article.
References
-
- Bass SJ, Sherman J, Giovinazzo V.. Bilateral Coats’ response in a female patient leads to diagnosis of facioscapulohumeral muscular dystrophy. Optometry 2011; 82: 72–6. - PubMed
-
- Chen TH, Lai YH, Lee PL, Hsu JH, Goto K, Hayashi YK, et al.Infantile facioscapulohumeral muscular dystrophy revisited: expansion of clinical phenotypes in patients with a very short EcoRI fragment. Neuromuscul Disord 2013; 23: 298–05. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources